BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8880017)

  • 1. Tissue plasminogen activator, tissue plasminogen activator inhibitor and lipoprotein(a) in patients with coronary, epiaortic and peripheral occlusive artery disease.
    Caputo M; Mantini G; Floriani I; Ciceri M; Noseda A; Bonomo L
    Eur Heart J; 1996 Sep; 17(9):1329-36. PubMed ID: 8880017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
    Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
    Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
    Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
    Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease.
    Olofsson BO; Dahlén G; Nilsson TK
    Eur Heart J; 1989 Jan; 10(1):77-82. PubMed ID: 2495219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue plasminogen activator and inhibitor and the severity and extensiveness of vascular lesions in peripheral atherosclerosis of the legs].
    Rość D; Zekanowska E; Hryncewicz W; Cwiklińska-Jurkowska M; Jurkowski P; Kotschy M
    Pol Merkur Lekarski; 1996 Oct; 1(4):235-7. PubMed ID: 9156932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise training enhances endogenous fibrinolysis in peripheral arterial disease.
    Killewich LA; Macko RF; Montgomery PS; Wiley LA; Gardner AW
    J Vasc Surg; 2004 Oct; 40(4):741-5. PubMed ID: 15472603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis.
    Jovin IS; Müller-Berghaus G
    Atherosclerosis; 2004 Jun; 174(2):225-33. PubMed ID: 15136052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
    Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states.
    Niwano H; Takahashi H; Tatewaki W; Wada K; Seki Y; Shibata A
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):389-93. PubMed ID: 1420814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
    Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B
    J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction.
    Ganti AK; Potti A; Yegnanarayan R
    Pathophysiol Haemost Thromb; 2002; 32(2):80-4. PubMed ID: 12214153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease].
    Chen ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Jun; 21(3):163-4, 188. PubMed ID: 8243232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease.
    Philips M; Juul AG; Selmer J; Lind B; Thorsen S
    Thromb Haemost; 1992 Nov; 68(5):486-94. PubMed ID: 1455392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
    Hevey D; McGee HM; Fitzgerald D; Horgan JH
    Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
    J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
    Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
    Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.
    Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y
    J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.
    Chen F; Eriksson P; Hansson GK; Herzfeld I; Klein M; Hansson LO; Valen G
    Int J Mol Med; 2005 Jan; 15(1):57-65. PubMed ID: 15583828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.